Grove Biopharma: Funding, Investors & Team (Sep 2026)
Grove Biopharma is a biotechnology company that provides a materials science solution to address challenges in peptide therapeutics. They are dedicated to discovering and developing a unique type of polymer, similar to proteins, to address the needs of patients with chronic inflammatory and neurodegenerative diseases.
Grove Biopharma has raised $30.0M across 1 funding round on record, the most recent a Series A of $30.0M announced in Apr 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Grove Biopharma Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Grove Biopharma Funding Rounds
Grove Biopharma Founders and Leadership Team
Contact details for the Grove Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Grove Biopharma Funding Compared to Other Biotechnology Startups
Grove Biopharma's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Grove Biopharma in Biotechnology and Chicago
Companies Similar to Grove Biopharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Grove Biopharma Funding FAQs
What does Grove Biopharma do?
Grove Biopharma is a biotechnology company that provides a materials science solution to address challenges in peptide therapeutics. They are dedicated to discovering and developing a unique type of polymer, similar to proteins, to address the needs of patients with chronic inflammatory and neurodegenerative diseases.
How much funding has Grove Biopharma raised?
Grove Biopharma has raised $30.0M across 1 round on record. The most recent is a Series A of $30.0M announced in Apr 2025.
When did Grove Biopharma last raise funding?
Grove Biopharma's most recent funding round on record is a Series A of $30.0M, announced in Apr 2025.
Who founded Grove Biopharma?
FundedIQ lists Paul Bertin (Founder) at Grove Biopharma.
Where is Grove Biopharma headquartered?
Grove Biopharma is based in Chicago, Illinois, United States.
How many employees does Grove Biopharma have?
Grove Biopharma is in the 11-50 employee band.
How does Grove Biopharma's funding compare to other Biotechnology startups?
Grove Biopharma's latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Grove Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Grove Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.